Skip to content
Search

Latest Stories

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.


His career at Rowlands has spanned multiple roles, including pharmacist manager, clinical governance pharmacist, and quality and clinical governance manager, before his recent promotion to deputy superintendent pharmacist.

Martin leads on patient safety and clinical governance standards for the Rowlands.

Within the CPPSG, Martin has led work on liquid medicines and represented the Group at the National Paediatric Medication Safety Officer (MSO) meetings and NHS England’s Pharmacy Integration Clinical Reference Group.

His appointment follows the passing of Dr. José Moss in January 2025. A founding member of the CPPSG, José became its vice-chair in 2024.

CPPSG chair Jackie Giltrow welcomed Martin’s appointment, stating: “Martin has always been a very active member of the Group and represents us at many external meetings.

“I know that Martin will be an absolute asset and provide invaluable support in enabling the Group to build on our previous work plus work towards future improvements in patient safety.

“The Group is instrumental in promoting patient safety and driving improvements in community pharmacy. We will continue to have a laser focus on patient safety in this new era of community pharmacy”.

Martin expressed his gratitude to his peers for entrusting him with the role of vice-chair and reaffirmed his commitment to supporting patient safety in community pharmacy.

After 10 years with the CPPSG, I’m honoured to become vice chair,” he said.

Martin emphasised that the work of the Group, particularly ‘sharing and learning’, is essential to enable community pharmacists to continually improve patient care.

“I’m also keen to ensure that we continue to connect with external groups to work effectively across the system to ensure patient safety remains at the heart of our work,” he added.

Formed in 2015, the CPPSG brings together MSOs from community pharmacies, focussing on sharing and learning from dispensing incidents to embed a culture of patient safety across the entire sector.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less